-
FB1006: AI-discovered drug advances to clinical trials for ALS treatment
Medical Mythbusting Commentary for February 29, 2024 Source:FB1006: AI-discovered drug advances to clinical trials for ALS treatment
-
Blood test for ALS undergoing trials for efficacy. If successful, how will this change the management of an untreatable (presently) terminal disease? It could provide an increased lead time to prepare support services.
Medical Mythbusting Commentary for September 8, 2022 Source:Blood Test Shows Promise for Quick Diagnosis of ALS Reference:Company press release
-
Observational study cannot establish link between increased ALS risk and mercury in fish
Health Headlines Commentary for February 21, 2017 Source: Mercury in fish, seafood may be linked to higher risk of ALS, study suggests Reference: that will be presented at the American Academy of Neurology’s 69th annual meeting in Boston in April 2017.
-
Study offers new insight into possible treatment for Lou Gehrig's disease (ALS)
Madely Health Headlines Commentary for June 13, 2014 Source: Findings point toward one of first therapies for Lou Gehrig’s disease Reference: Oral Treatment with CuII(atsm) Increases Mutant SOD1 In Vivo but Protects Motor Neurons and Improves the Phenotype of a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis. Journal of Neuroscience, 2014; 34 (23): 8021 DOI: 10.1523/JNEUROSCI.4196-13.2014
-
Former US ambassador Cellucci diagnosed with ALS
Madely Health Headlines Commentary for January 7, 2011 [display_podcast] Source: Ex-ambassador Cellucci has Lou Gehrig’s: report